Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
Eli Muchtar(Mayo Clinic), Taimur Sher(Mayo Clinic in Florida), Jeremy T. Larsen(City of Hope), P. Leif Bergsagel(Mayo Clinic in Arizona), David Dingli, Francis K. Buadi, Morie A. Gertz(Medical University of South Carolina), Nelson Leung(WinnMed), Dragan Jevremović(Mayo Clinic in Arizona), Robert A. Kyle(Mayo Clinic), Shaji Kumar(Mayo Clinic), Craig B. Reeder(Mayo Clinic in Arizona), Julie Rosenthal(WinnMed), Ronald S. Go(Mayo Clinic), Prashant Kapoor, Michelle L. Mauermann(Anna Needs Neuroblastoma Answers), Amie Fonder, Yi L. Hwa, Sikander Ailawadhi(Jacksonville College), Omar F. Abou Ezzeddine(Mayo Clinic in Arizona), Stephen J. Russell(University of Minnesota Rochester), David Murray(Unknown), Ellen D. McPhail(Mayo Clinic), Rahma Warsame, Surendra Dasari(Mayo Clinic in Arizona), S. Vincent Rajkumar(WinnMed), Wilson I. Gonsalves(Mayo Clinic in Arizona), Martha Grogan(Mayo Clinic in Arizona), Taxiarchis Kourelis(Mayo Clinic in Arizona), Martha Q. Lacy(Mayo Clinic), Yi Lin, Vivek Roy(Jacksonville College), Suzanne R. Hayman, John A. Lust, Angela Dispenzieri(Mayo Clinic), Miriam Hobbs, Rafaël Fonseca(Mayo Clinic in Arizona)
Cited by 86
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k